In our study, DPR attenuates obesity‐induced cardiac remodeling during aging, as evidenced by the normalization of heart weight and the suppression of hypertrophic markers, including Cyclin D1, NPPA, and DDB1. This evidence concerns the gene CCND1 and obesity due to melanocortin 4 receptor deficiency.